Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

NCT00179647 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1913

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

Celgene Corporation

Collaborators

[object Object]